Evidence map›Paper›PMID 41630141›Full record

ArticleAdvanced healthcare materials2026

SiO

David R Sory, Agathe C M Heyraud, Julian R Jones, Sara M Rankin

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David R SoryNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-3392-9353
Agathe C M HeyraudDepartment of Materials, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-2292-2132
Julian R JonesDepartment of Materials, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-2647-8024
Sara M RankinNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-2194-4089

Funding

BBSRC BB/L015129/1EPSRC EP/S025782/1EPSRC EP/W034093/1EPSRC EP/X52556X/1National Heart and Lung Institute at Imperial College LondonWellcome Trust 104931/Z/14/Z
6 · The paper itself

Abstract

This article addresses the unmet clinical need of scaffolds for bone regeneration that can combine osteogenic properties, such as the promotion of bone marrow stem cell differentiation into osteoblasts, with the ability to withstand cyclic loading. In our previous study, we demonstrated that discs of SiO

Indexed as

Cell DifferentiationFuransMesenchymal Stem CellsOsteogenesisPolyestersPrinting, Three-DimensionalSilicon DioxideTissue ScaffoldsButylene GlycolsCell ProliferationCells, CulturedHumansPolymersTissue EngineeringButylene GlycolsFuranspolycaprolactonePolyestersPolymerspoly(tetrahydrofuran)Silicon Dioxidebioactive inorganic/organic hybridsbone tissue engineeringhuman‐bone marrow stromal cellsosteogenic differentiationsol‐gel

Identifiers

PMID41630141
PMCPMC13175292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.